Synthetic cannabinoids use in a sample of opioid-use disorder patients.

Alías-Ferri M, Pellegrini M, Marchei E, Pacifici R, Rotolo MC, Pichini S, Pérez-Mañá C, Papaseit E, Muga R, Fonseca F, Farré M, Torrens M

Open source

DOI: 10.3389/fpsyt.2022.956120
Published: 2022
Container: Frontiers in psychiatry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fpsyt.2022.956120,
  title = {Synthetic cannabinoids use in a sample of opioid-use disorder patients.},
  author = {Alías-Ferri M and Pellegrini M and Marchei E and Pacifici R and Rotolo MC and Pichini S and Pérez-Mañá C and Papaseit E and Muga R and Fonseca F and Farré M and Torrens M},
  year = {2022},
  journal = {Frontiers in psychiatry},
  doi = {10.3389/fpsyt.2022.956120},
  url = {https://doi.org/10.3389/fpsyt.2022.956120}
}

RIS

TY  - JOUR
TI  - Synthetic cannabinoids use in a sample of opioid-use disorder patients.
AU  - Alías-Ferri M
AU  - Pellegrini M
AU  - Marchei E
AU  - Pacifici R
AU  - Rotolo MC
AU  - Pichini S
AU  - Pérez-Mañá C
AU  - Papaseit E
AU  - Muga R
AU  - Fonseca F
AU  - Farré M
AU  - Torrens M
PY  - 2022
JO  - Frontiers in psychiatry
DO  - 10.3389/fpsyt.2022.956120
UR  - https://doi.org/10.3389/fpsyt.2022.956120
ER  -

APA

M, A., M, P., E, M., R, P., MC, R., S, P., C, P., E, P., R, M., F, F., M, F., & M, T. (2022). Synthetic cannabinoids use in a sample of opioid-use disorder patients.. Frontiers in psychiatry. https://doi.org/10.3389/fpsyt.2022.956120

Source records

pubmed · retrieved 2026-09-25T09:12:30.649Z